Senior VP and Exec. Global Program Head, CART Global Program Team @ Novartis
Senior VP and Exec. Global Program Head, CTL019, Cell and Gene Therapies Unit, Novartis @ Novartis
Senior VP and Exec. Global Program Head, CTL019, Cell and Gene Therapies Unit, Novartis @ Novartis
Sr. VP and Global Head, Oncology Clinical Development @ Novartis
Senior Vice President and Global Program Head, Afinitor and MEK162/LGX818 @ Novartis
Vice President and Global Program Head, Afinitor @ Novartis
Vice President, Oncology Clinical Development @ Novartis
David Lebwohl's Education
Yale University
Doctor of Medicine (Medicine)
1977 - 1981
Harvard University
Bachelor of Arts
David Lebwohl's Skills
Clinical Development
Oncology
Clinical Trials
Pharmaceutical Industry
Drug Development
Translational Medicine
Clinical Research
GCP
CRO
Hematology
David Lebwohl's Summary
David Lebwohl, based in Madison, NJ, US, is currently a Chief Medical Officer at Intellia Therapeutics, Inc., bringing experience from previous roles at Semma Therapeutics and Novartis. David Lebwohl holds a 1977 - 1981 Doctor of Medicine in Medicine @ Yale University. With a robust skill set that includes Clinical Development, Oncology, Clinical Trials, Pharmaceutical Industry, Drug Development and more, David Lebwohl contributes valuable insights to the industry. David Lebwohl has 3 emails and 1 mobile phone number on RocketReach.